To determine whether HAS2 expression is related to inflammation within human breast cancer samples, we examined the expression levels of inflammatory and other stromal-related genes in a cohort (n = 94) of human breast cancer samples (Figure S7), using a custom 356 gene codeset on the NanoString nCounter platform (Figure S6). Here, HAS2 is linked to breast carcinoma.